Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This review addresses the causes, mechanisms, and treatment options for the most common non-scarring alopecias in females, including telogen effluvium, alopecia areata, and female pattern hair loss.

This source highlights that alopecia areata is a complex autoimmune disorder leading to patchy, nonscarring hair loss with variable treatment responses, reflecting unmet clinical needs. Advances in genetic research are improving understanding, yet current treatments often lead to persistent relapses.

This study found that Platelet Rich Plasma treatment may safely and effectively promote hair regrowth in patients with pattern hair loss, especially when combined with other topical drugs like finasteride and minoxidil.

Ultrasound can improve targeted drug delivery, making treatments more effective with fewer side effects.

Finasteride and minoxidil are effective, low-risk treatments for male hair loss, and patient education on these therapies is important.

Over 40% of postmenopausal women experience hair loss, with treatments aiming to stop further loss and possibly thicken hair.

Stopping the use of a tight headband and using specific treatments led to partial hair regrowth.

This review addresses the challenges in treating frontal fibrosing alopecia, highlighting the limited effectiveness of medical treatments and the demand for hair transplantation despite its risks, but it reports no new clinical results.

This article describes the diagnostic process and rewards of evaluating female hair loss but reports no new clinical findings.

In this retrospective observational study, researchers found that the Dean Scale showed better diagnostic accuracy than the CTCAE scale for detecting clinician-reported therapeutic responses to minoxidil in patients with anticancer therapy-induced alopecia, but both scales had limitations in recording clinically significant hair regrowth.

This study reviews female hair loss conditions with a focus on diagnosis and treatment. It highlights female pattern hair loss as the most common form and emphasizes the need for personalized therapy, including topical minoxidil and, when appropriate, antiandrogen treatments.

This review discusses androgenetic alopecia, outlining its genetic and hormonal causes, and summarizes current and emerging treatments like minoxidil, finasteride, and low-dose oral therapies, emphasizing the need for more research to confirm the efficacy and safety of newer approaches.

This case report describes a unique instance of late-onset Björnstad syndrome in an 18-year-old female, mimicking androgenetic alopecia, and indicates potential improvement with JAK inhibitor baricitinib, highlighting the need for considering this syndrome in similar cases of patterned hair loss in young individuals.

This case report highlights that early signs like pili torti may precede lichen planopilaris in some patients, emphasizing the importance of timely intervention to prevent permanent hair loss.

In this case report, a woman with unexplained hair loss and high ANA levels developed systemic lupus erythematosus, highlighting the importance of monitoring autoantibodies for early lupus detection and management.

In this systematic review, the researchers observed that topical caffeine preparations appear safe and effective against hair loss, but most studies had low-quality evidence due to design flaws, indicating the need for better-designed trials before drawing definitive conclusions.

This case report describes a 28-year-old woman who developed alopecia areata following prolonged emotional stress, with improvement observed using Minoxidil and stress management, but relapse occurred after another stressful period.

Early diagnosis and treatment can help manage fibrosing alopecia in older women.

This report describes a rare case of loose anagen hair syndrome in a young Indian child, highlighting its clinical and trichoscopic features.

This case report presented the successful treatment of a patient with alopecia universalis using tofacitinib.

This review discusses the characteristics, causes, diagnosis, and treatment options for androgenetic alopecia and emphasizes the importance of managing expectations due to the variability in therapeutic outcomes.

This systematic review reported that gender-affirming hormone therapy may lead to changes in hair growth patterns, with differing effects for transgender men and women, potentially impacting quality of life.

In this study, a 24-year-old patient with severe alopecia areata showed an excellent clinical response to the JAK inhibitor tofacitinib after one month, following unsuccessful previous treatments.

This review discusses telogen effluvium, including its causes, symptoms, diagnostic methods, and treatment strategies, without presenting new clinical findings.

This article discusses the clinical features and treatment options for common types of hair loss in women and reports no new clinical results.

This review discusses frontal fibrosing alopecia, noting its clinical characteristics, possible environmental factors, and lack of evidence-based therapies, but reports no new research findings.

This study compiles current scientific knowledge on female pattern hair loss for aesthetic physicians, but it does not present new clinical findings.

This case report discusses the diagnosis and management of temporal triangular alopecia in a pediatric patient experiencing asymptomatic hair loss, emphasizing its nonprogressive nature and poor prognosis for regrowth.

The conclusion is that managing hair loss conditions like FFA and melanoma requires individualized approaches, considering new findings and balancing treatment benefits with potential risks.

This review discusses current and emerging treatments for androgenic alopecia, noting that minoxidil and finasteride are the only FDA-approved options, while other methods lack comparable evidence of efficacy.